How many studies have been conducted on Viomycin?

BiohacksAI has indexed 300 PubMed studies on Viomycin. 3% of studies involve human subjects.

What are the main research areas for Viomycin?

The primary research domains for Viomycin are 🫁 Respiratory, 🫘 Kidney, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Viomycin

A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.

300+ PubMed studies analyzed · Evidence Score: 41

Research Domains

Viomycin has been studied across 9 research domains including 🫁 Respiratory, 🫘 Kidney, 🧠 Focus & Attention, 🔥 Metabolic, 🏋️ Muscle & Hypertrophy. The primary research focus is 🫁 Respiratory with 19% of studies addressing this area.

Loading evidence profile...

This evidence profile for Viomycin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.